Effect on smoking quit rate of telling patients their lung age: The Step2quit randomised controlled trial

BMJ

Volumn 336, Issue 7644, 2008, Pages 598-600

  Parkes, Gary ^a   Greenhalgh, Trisha ^b   Griffin, Mark ^b   Dent, Richard ^c  

^a The Limes Surgery   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FORCED EXPIRATORY VOLUME; GENERAL PRACTICE; HEALTH CARE COST; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; NATIONAL HEALTH SERVICE; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT REFERRAL; PRIORITY JOURNAL; SALIVA ANALYSIS; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SPIROMETRY; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; AGE; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; LUNG DISEASE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SMOKING; STATISTICS; VITAL CAPACITY;

ADULT; AGE FACTORS; AGED; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES; MIDDLE AGED; PROGNOSIS; SMOKING; SMOKING CESSATION; SPIROMETRY; VITAL CAPACITY;

EID: 40949139693     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39503.582396.25     Document Type: Article

References (12)

1. Morris JF, Temple W. Spirometric "lung age" estimation for motivating smoking cessation. Prev Med 1985;14:655-62.
2. Bize R, Burnand B, Mueller Y, Comuz J. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev 2005;(4):CD004705.
3. Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006;61:869-73.
4. British Thoracic Society. Clinical information. COPD. www.brit-thoracic.org.uk/ClinicalInformation/tabid/66/Default.aspx.
5. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med 1991;85(suppl B):25-31.
6. Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002;324:1370.
7. McClure JB. Are biomarkers a useful aid in smoking cessation? A review and analysis of the literature. Behav Med 2001;27:37-47.
8. Lancaster T, Stead LF. Physician advice for smoking cessation. Cochrane Database Syst Rev 2004;(4):CD000165.
9. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004;(3):CD000146.
10. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2004;(4):CD000031.
11. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2005;(2):CD001292.
12. Stead LF, Lancaster T, Perera R. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2003;(1):CD002850.